alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
HomeOffice of the SpokespersonPress Releases...Sanctioning a Network Supporting Iran’s Aircraft Procurement and Unmanned Aerial Vehicles Activities

# 									Sanctioning a Network Supporting Iran’s Aircraft Procurement and Unmanned Aerial Vehicles Activities							

Press Statement

Antony J. Blinken, Secretary of State

March 9, 2023

The United States is designating five entities and one individual based in the People’s Republic of China for sanctions pursuant to Executive Order (E.O.) 13382, which targets proliferators of weapons of mass destruction and their means of delivery. 

This network is responsible for the sale and shipment of thousands of components, including those used in Shahed-series UAVs, to the Iran Aircraft Manufacturing Industrial Company (HESA), which was designated pursuant to E.O. 13382 in September 2008. Those designated today facilitated transactions for components for fixed-wing, rotorcraft, and UAV applications.

The United States will continue to use every tool at our disposal to disrupt these efforts and work with allies and partners to hold Iran accountable for its actions.

For more information on today’s action, please see the Department of the Treasury’spress release.

Tags

Bureau of International Security and NonproliferationChinaDivision for Counter Threat Finance and SanctionsIranOffice of the SpokespersonSanctionsThe Secretary of StateWeaponsWeapons of Mass Destruction

Back to Top
#### § 141.11 Federal savings association.

The term *Federal savings association* means a Federal savings association or Federal savings bank chartered under section 5 of the Act.
#### § 160.36 De minimis investments.

A Federal savings association may invest in the aggregate up to the greater of 1% of its total capital or $250,000 in community development investments of the type permitted for a national bank under 12 CFR part 24.
# C_2021320EN.01000101.xml

| 9.8.2021 | EN | Official Journal of the European Union | C 320/1 |
| --- | --- | --- | --- |

9.8.2021

EN

Official Journal of the European Union

C 320/1

---

Last publications of the Court of Justice of the European Union in the Official Journal of the European Union

(2021/C 320/01)

Last publication

OJ C 310, 2.8.2021

Past publications

OJ C 297, 26.7.2021

OJ C 289, 19.7.2021

OJ C 278, 12.7.2021

OJ C 263, 5.7.2021

OJ C 252, 28.6.2021

OJ C 242, 21.6.2021

These texts are available on:

EUR-Lex: http://eur-lex.europa.eu

---
# C_2022305EN.01000801.xml

| 10.8.2022 | EN | Official Journal of the European Union | C 305/8 |
| --- | --- | --- | --- |

10.8.2022

EN

Official Journal of the European Union

C 305/8

---

Euro exchange rates (1)

9 August 2022

(2022/C 305/04)

1 euro =

1 euro =

| | Currency | Exchange rate |
| --- | --- | --- |
| USD | US dollar | 1,0234 |
| JPY | Japanese yen | 138,26 |
| DKK | Danish krone | 7,4407 |
| GBP | Pound sterling | 0,84520 |
| SEK | Swedish krona | 10,3875 |
| CHF | Swiss franc | 0,9763 |
| ISK | Iceland króna | 140,10 |
| NOK | Norwegian krone | 9,9365 |
| BGN | Bulgarian lev | 1,9558 |
| CZK | Czech koruna | 24,532 |
| HUF | Hungarian forint | 397,35 |
| PLN | Polish zloty | 4,7085 |
| RON | Romanian leu | 4,9038 |
| TRY | Turkish lira | 18,3342 |
| AUD | Australian dollar | 1,4687 |
| CAD | Canadian dollar | 1,3163 |
| HKD | Hong Kong dollar | 8,0334 |
| NZD | New Zealand dollar | 1,6304 |
| SGD | Singapore dollar | 1,4110 |
| KRW | South Korean won | 1 336,74 |
| ZAR | South African rand | 17,0500 |
| CNY | Chinese yuan renminbi | 6,9106 |
| HRK | Croatian kuna | 7,5140 |
| IDR | Indonesian rupiah | 15 197,09 |
| MYR | Malaysian ringgit | 4,5592 |
| PHP | Philippine peso | 56,939 |
| RUB | Russian rouble | |
| THB | Thai baht | 36,264 |
| BRL | Brazilian real | 5,2478 |
| MXN | Mexican peso | 20,7145 |
| INR | Indian rupee | 81,4060 |

Currency

Exchange rate

USD

US dollar

1,0234

JPY

Japanese yen

138,26

DKK

Danish krone

7,4407

GBP

Pound sterling

0,84520

SEK

Swedish krona

10,3875

CHF

Swiss franc

0,9763

ISK

Iceland króna

140,10

NOK

Norwegian krone

9,9365

BGN

Bulgarian lev

1,9558

CZK

Czech koruna

24,532

HUF

Hungarian forint

397,35

PLN

Polish zloty

4,7085

RON

Romanian leu

4,9038

TRY

Turkish lira

18,3342

AUD

Australian dollar

1,4687

CAD

Canadian dollar

1,3163

HKD

Hong Kong dollar

8,0334

NZD

New Zealand dollar

1,6304

SGD

Singapore dollar

1,4110

KRW

South Korean won

1 336,74

ZAR

South African rand

17,0500

CNY

Chinese yuan renminbi

6,9106

HRK

Croatian kuna

7,5140

IDR

Indonesian rupiah

15 197,09

MYR

Malaysian ringgit

4,5592

PHP

Philippine peso

56,939

RUB

Russian rouble

THB

Thai baht

36,264

BRL

Brazilian real

5,2478

MXN

Mexican peso

20,7145

INR

Indian rupee

81,4060

---

(1)  
  Source: reference exchange rate published by the ECB.

1

Source

---
Exhibit 31.2





CERTIFICATION PURSUANT TO RULE 13a-15(e) OR 15d-15(e) OF THE SECURITIES EXCHANGE 
ACT OF 1934, AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002



I, Tam Cheuk Ho, certify that:



1.

I have reviewed this quarterly report on Form 10-QSB of China Resources Development, Inc.;



2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;



3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the small business issuer as of, and for, the periods presented in this report;



4.

The small business issuer's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the small business issuer and have:

a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the small business issuer, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) evaluated the effectiveness of the small business issuer's disclosure controls and procedures and presented in this report our conclusion about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

c) disclosed in this report any change in the small business issuers internal control over financial reporting that occurred during the small business issuers most recent fiscal quarter (the small business issuers fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the small business issuers internal control over financial reporting; and;

5.

The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the small business issuers auditors and the audit committee of small business issuer's board of directors (or persons performing the equivalent functions):

a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the small business issuer's ability to record, process, summarize and report financial information; and

b) any fraud, whether or not material, that involves management or other employees who have a significant role in the small business issuer's internal control over financial reporting.



Date:  November 15, 2004



/s/ Tam Cheuk Ho



Chief Financial Officer
# C_2022148EN.01000101.xml

| 4.4.2022 | EN | Official Journal of the European Union | C 148/1 |
| --- | --- | --- | --- |

4.4.2022

EN

Official Journal of the European Union

C 148/1

---

Last publications of the Court of Justice of the European Union in the Official Journal of the European Union

(2022/C 148/01)

Last publication

OJ C 138, 28.3.2022

Past publications

OJ C 128, 21.3.2022

OJ C 119, 14.3.2022

OJ C 109, 7.3.2022

OJ C 95, 28.2.2022

OJ C 84, 21.2.2022

OJ C 73, 14.2.2022

These texts are available on:

EUR-Lex: http://eur-lex.europa.eu

---
United States Court of Appeals

For the First Circuit

No. 04-1853

UNITED STATES OF AMERICA,

Appellee,

v.

JULIO PÉREZ-RUIZ,

Defendant, Appellant.

ERRATA

The opinion of this Court, issued on August 26, 2005, should

be amended as follows:

On page 6, line 7 of 1st paragraph, replace "2005 WL 1491483,

at *2 (1st Cir. June 24, 2005)," with "110 (1st Cir. 2005),".

On page 6, line 14 of 1st paragraph, replace "*3" with "111".
# C_2023262EN.01000301.xml

| 25.7.2023 | EN | Official Journal of the European Union | C 262/3 |
| --- | --- | --- | --- |

25.7.2023

EN

Official Journal of the European Union

C 262/3

---

New national side of euro coins intended for circulation

(2023/C 262/03)

Image 1

National side of the new commemorative 2-euro coin intended for circulation and issued by Greece

Euro coins intended for circulation have legal tender status throughout the euro area. For the purpose of informing the public and all parties who handle the coins, the Commission publishes a description of the designs of all new coins (1). In accordance with the Council conclusions of 10 February 2009 (2), euro-area Member States and countries that have concluded a monetary agreement with the European Union providing for the issuing of euro coins are allowed to issue commemorative euro coins intended for circulation, provided that certain conditions are met, particularly that only the 2-euro denomination is used. These coins have the same technical characteristics as other 2-euro coins, but their national face features a commemorative design that is highly symbolic in national or European terms.

Issuing country: Greece

Subject of commemoration: 150 years from the birth of Constantin Carathéodory

Description of the design: The design features a portrait of the Greek mathematician Constantin Carathéodory. Inscribed along the inner edge at the left is the wording ‘CONSTANTIN CARATHÉODORY 1873-1950’, and at right the minting year ‘2023’ and a palmette (mintmark of the Greek Mint); below the portrait runs the inscription ‘HELLENIC REPUBLIC’.

The coin’s outer ring depicts the 12 stars of the European flag.

Estimated number of coins to be issued: 750 000

Date of issue: July 2023

---

(1)  See OJ C 373, 28.12.2001, p. 1 for the national faces of all the coins issued in 2002.

(2)  See the conclusions of the Economic and Financial Affairs Council of 10 February 2009 and the Commission Recommendation of 19 December 2008 on common guidelines for the national sides and the issuance of euro coins intended for circulation (OJ L 9, 14.1.2009, p. 52).

---
[Federal Register Volume 74, Number 186 (Monday, September 28, 2009)]
[Notices]
[Page 49385]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E9-23085]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute on Drug Abuse; Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel B/START Review.
    Date: October 15, 2009.
    Time: 9 a.m. to 11:30 a.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6101 Executive Boulevard, 
Rockville, MD 20852, (Virtual Meeting).
    Contact Person: Gerald L. McLaughlin, PhD, Scientific Review 
Administrator, Office of Extramural Affairs, National Institute on 
Drug Abuse, NIH, DHHS, Room 220, MSC 8401, 6101 Executive Blvd., 
Bethesda, MD 20892-8401, 301-402-6626, <a href="/cdn-cgi/l/email-protection#b9ded4888d8cd8f9d7d0d197ded6cf"><span class="__cf_email__" data-cfemail="90f7fda1a4a5f1d0fef9f8bef7ffe6">[email protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos. 93.279, Drug 
Abuse and Addiction Research Programs, National Institutes of 
Health, HHS).

    Dated: September 18, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. E9-23085 Filed 9-25-09; 8:45 am]
BILLING CODE M


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
HomeOffice of the SpokespersonPress Releases...Reverend Samson’s Prison Sentence

# 									Reverend Samson’s Prison Sentence							

Press Statement

Vedant Patel, Principal Deputy Spokesperson

April 17, 2023

We join the international community in condemning the sentencing of Reverend Dr. Hkalam Samson and call for his immediate and unconditional release.  On April 7, the Myitkyina Prison in Burma’s Kachin State sentenced Dr. Samson to six years in prison on military-led, manufactured charges of terrorism, unlawful association, and inciting opposition to the regime in Burma.  Burma’s brutal military regime has targeted Rev. Dr. Samson, a prominent, well-respected religious figure, for his courageous work, including advocating for freedom of religion or belief.  Reverend Dr. Samson has devoted his pastoral career to supporting peace efforts, drug eradication, advocating for justice and equality for Kachin Christians and throughout Burma, and facilitating the safe and voluntary return of more than 100,000 displaced Kachin people to their homes.  We urge the regime to cease its unconscionable repression against religious actors, communities, and houses of worship in Burma and end the violence.

Tags

Bureau of East Asian and Pacific AffairsBurmaOffice of the SpokespersonReligious FreedomThe Secretary of State

Back to Top
#### § 1408.1 Authority.

The regulations of this part are issued under the Federal Claims Collection Act of 1966, as amended by the Debt Collection Act of 1982, 31 U.S.C. 3701-3719 and 5 U.S.C. 5514, and in conformity with the joint regulations issued under that Act by the General Accounting Office and the Department of Justice (joint regulations) prescribing standards for administrative collection, compromise, suspension, and termination of agency collection actions, and referral to the General Accounting Office and to the Department of Justice for litigation of civil claims for money or property owed to the United States (4 CFR parts 101-105).
<PAGE>

                                                                   EXHIBIT 10.17

1 March 1999


SeaPoint Ventures
777 108th Avenue NE
Suite 1895
Bellevue, WA  98004



Dear Sirs:

This letter sets forth the mutual understanding between SeaPoint Ventures, LLC
("SeaPoint") and Airspan Communications Corporation ("Airspan") with respect to
the services SeaPoint will provide Airspan.

Thomas S. Huseby, managing partner and owner of SeaPoint, will perform as
Chairman of Airspan until such time as the Board of Directors of Airspan elect
to terminate or modify this position.

Additionally, SeaPoint will provide administrative services to Airspan for
support of its US ownership as needed until such time that they are no longer
needed.

During the term of this agreement, Airspan agrees to pay SeaPoint $22,500 per
month for services beginning March 1, 1999 as detailed below.

                                                        US$
                                                       ------
Thomas S. Huseby
Chairman                                               12,500
Susan Sigl, Donna Hayataka & Stacy Burk
Administrative support                                 10,000
                                                       ------
                                                       22,500
                                                       ------

Airspan will also reimburse SeaPoint for travel expenses incurred by SeaPoint in
performing these services.  Payments by Airspan to SeaPoint will be due in
arrears on the last day of the month.

If the foregoing is acceptable to you, would you please so acknowledge in the
space provided below and return your signed acknowledgement to us, whereupon
this agreement will become a binding agreement between us.
<PAGE>

SEAPOINT VENTURES, LLC


By: /s/ Thomas Huseby
   --------------------------------
          Thomas S. Huseby
            Its Manager



The foregoing terms are hereby accepted and agreed this
10th day of March 1999


AIRSPAN COMMUNICATIONS CORPORATION


By: /s/ Eric Stonestrom
   --------------------------------
          Eric Stonestrom
    Its Chief Executive Officer


BOARD OF DIRECTORS OF AIRSPAN COMMUNICATIONS CORPORATION

/s/ Jon Bayless                                  /s/ Ovid Santoro
------------------------------                   -------------------------------
Jon Bayless                                      Ovid Santoro


/s/ Bandel Carano                                /s/ Thomas Huseby
------------------------------                   -------------------------------
Bandel Carano                                    Thomas S. Huseby


/s/ Barry Cash                                   /s/ David Twyver
------------------------------                   -------------------------------
Barry Cash                                       David Twyver


                                                 /s/ Eric Stonestrom
                                                 -------------------------------
                                                 Eric Stonestrom


                                      -2-
<TABLE> <S> <C>

<ARTICLE> 5
       
<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          JAN-02-1998
<PERIOD-END>                               JUL-04-1997
<CASH>                                           2,334
<SECURITIES>                                         0
<RECEIVABLES>                                   25,453
<ALLOWANCES>                                       526
<INVENTORY>                                        646
<CURRENT-ASSETS>                                38,240
<PP&E>                                         179,254
<DEPRECIATION>                                  62,538
<TOTAL-ASSETS>                                 155,466
<CURRENT-LIABILITIES>                           22,598
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                         4,559
<OTHER-SE>                                      61,043
<TOTAL-LIABILITY-AND-EQUITY>                   155,466
<SALES>                                              0
<TOTAL-REVENUES>                               126,530
<CGS>                                                0
<TOTAL-COSTS>                                  126,147
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                               2,115
<INCOME-PRETAX>                                (1,689)
<INCOME-TAX>                                     (625)
<INCOME-CONTINUING>                            (1,064)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   (1,064)
<EPS-PRIMARY>                                   (0.24)
<EPS-DILUTED>                                   (0.24)
        

</TABLE>
<PAGE> 1


                                                        February 4, 1998

Kirkland & Ellis
200 East Randolph Drive
Chicago, Illinois  60601

        Re:     Warrants to purchase 250,000 of Common
                Stock of Cistron Biotechnology, Inc.
                --------------------------------------

Gentlemen:

        In consideration for your agreement to the terms set forth in your
letter dated October 17, 1997, Cistron Biotechnology, Inc. ("Cistron") 
agrees to amend the warrant dated December 6, 1996, entitling you to purchase
up to 250,000 shares of Cistron's Common Stock at $.50 per share.

        Pursuant to the terms of this letter agreement, you may elect to
exercise your warrants, as amended herein, and receive, without the payment of
any cash consideration, shares equal to the value of your warrants or any
portion thereof by the surrender of the warrants or such portion to Cistron.
Upon such surrender, Cistron shall issue to you such number of fully paid and
non-assessable shares of its Common Stock as is computed using the following
formula:

                                  X=Y(A-B)
                                    ------
                                      A

where X equals the number of shares to be issued to you, Y equals the 
number of shares covered by your warrants in respect of which this net 
issue election is made, A equals the fair market value of one share of 
Common Stock at the time the net issue election is made and B equals the 
exercise price in effect under your warrants at the time this net issue 
election is made.  The determination of fair market value shall be closing 
bid price of the Common Stock on the trading day immediately preceding the 
date of exercise or if there shall be no such closing bid price then as 
determined in good faith by Cistron's Board of Directors.

                                 -1-
<PAGE>2

        Except as modified herein, all terms and provisions of your 
warrants shall remain in full force and effect.

        Please indicate your agreement with the foregoing by signing below
where indicated below and returning a copy of this letter to me by fax 
and mail.

                                        Very truly yours,

                                        CISTRON BIOTECHNOLOGY, INC.

                                        By:/s/BRUCE C. GALTON
                                           ------------------
                                           BRUCE C. GALTON
                                           Acting Chairman and Chief
                                           Executive Officer

ACKNOWLEDGED AND ACCEPTED:

KIRKLAND & ELLIS

By: /s/ROBERT G. KRUPKA
    -------------------
Name:ROBERT G. KRUPKA
Title: PARTNER

                                     -2-
<PAGE>2
Exhibit 32  CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PUSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002  I certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Quarterly Report on Form 10-Q for the period ended January 31, 2009 fully complies with the requirements of Section 13 (a) or 15 (d) of the Securities Exchange Act of 1934 and that information contained in such Annual Report fairly presents in all material respect the financial condition and results of operations of Vitro Diagnostics, Inc.   Date:  March 19, 2009 By:_/s/ James R. Musick______ Name:  James R. Musick Title: President, Chairman, Chief Executive Officer and Principal Financial Officer Vitro Diagnostics, Inc.